Kolexia
Brezault-Bonnet Catherine
Gastro-entérologie
Hôpital Cochin
Paris, France
93 Activités
6 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Adénocarcinome Tumeurs colorectales Carcinomes Métastase tumorale Tumeurs du foie Tumeurs du pancréas Tumeurs neuroendocrines Tumeurs du côlon Sarcopénie

Industries

Ipsen
6 collaboration(s)
Dernière en 2021
Novartis
5 collaboration(s)
Dernière en 2020
B3TSI
4 collaboration(s)
Dernière en 2023
Servier
4 collaboration(s)
Dernière en 2023

Dernières activités

ADAGE: Randomised Phase III Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over Intergroup Trial: Ffcd, Gercor, Gerico, Unicancer-gi
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
Impact of Sarcopenia on Survival in Patients Treated with FOLFIRINOX in a First-Line Setting for Metastatic Pancreatic Carcinoma.
Journal of clinical medicine   13 mars 2023
Impact of Sarcopenia on Patients with Localized Pancreatic Ductal Adenocarcinoma Receiving FOLFIRINOX or Gemcitabine as Adjuvant Chemotherapy.
Cancers   14 décembre 2022
Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma?
ESMO open   16 novembre 2022
Endoscopic ultrasound efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study.
Annals of translational medicine   02 septembre 2022
Therapeutic Management of Advanced Hepatocellular Carcinoma: An Updated Review.
Cancers   10 mai 2022
Endoscopic ultrasound guided fine needle biopsy in patients with suspected gastric linitis plastica.
Clinics and research in hepatology and gastroenterology   14 mars 2022
Re: "Does surgery provide a survival advantage in nondisseminated poorly differentiated gastroenteropancreatic neuroendocrine neoplasms".
Surgery   25 janvier 2022
Systemic therapy in metastatic pancreatic adenocarcinoma: current practice and perspectives.
Therapeutic advances in medical oncology   06 juillet 2021
Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions.
Cancers   18 mai 2021